Capricor Therapeutics, Inc. - CAPR
About Gravity Analytica
Recent News
- 01.20.2026 - Capricor Therapeutics Provides Regulatory Update on Deramiocel BLA Following FDA Review of HOPE-3 Topline Data
- 01.20.2026 - Capricor Therapeutics Provides Regulatory Update on Deramiocel BLA Following FDA Review of HOPE-3 Topline Data
- 12.16.2025 - Capricor Therapeutics and Parent Project Muscular Dystrophy to Host Webinar Highlighting Positive Phase 3 HOPE-3 Topline Results in Duchenne Muscular Dystrophy
- 12.16.2025 - Capricor Therapeutics and Parent Project Muscular Dystrophy to Host Webinar Highlighting Positive Phase 3 HOPE-3 Topline Results in Duchenne Muscular Dystrophy
- 12.05.2025 - Capricor Therapeutics Announces Pricing of $150 Million Public Offering of Common Stock
- 12.05.2025 - Capricor Therapeutics Announces Pricing of $150 Million Public Offering of Common Stock
Recent Filings
- 01.07.2026 - 4 Statement of changes in beneficial ownership of securities
- 01.07.2026 - 4 Statement of changes in beneficial ownership of securities
- 01.07.2026 - 4 Statement of changes in beneficial ownership of securities
- 01.07.2026 - 4 Statement of changes in beneficial ownership of securities
- 01.07.2026 - 4 Statement of changes in beneficial ownership of securities
- 01.07.2026 - 4 Statement of changes in beneficial ownership of securities
- 01.07.2026 - 4 Statement of changes in beneficial ownership of securities
- 01.07.2026 - 4 Statement of changes in beneficial ownership of securities
- 01.07.2026 - 4 Statement of changes in beneficial ownership of securities
- 01.07.2026 - 4 Statement of changes in beneficial ownership of securities